نتایج جستجو برای: lymphoblastic leukemia

تعداد نتایج: 285800  

Journal: :Haematologica 2008
Paola Ballerini Judith Landman-Parker Jean Michel Cayuela Vahid Asnafi Myriam Labopin Virginie Gandemer Yves Perel Gérard Michel Thierry Leblanc Claudine Schmitt Sylvie Fasola Anne Hagemejier François Sigaux Marie Françoise Auclerc Luc Douay Guy Leverger André Baruchel

BACKGROUND The prognostic value of the ectopic activation of TLX3 gene expression, a major oncogenetic event associated with pediatric T-cell acute lymphoblastic leukemia, is controversial. Likewise, the frequency and the prognostic significance in pediatric T-cell acute lymphoblastic leukemia of the newly characterized NUP214-ABL1 fusion transcript is not yet clear. DESIGN AND METHODS Two hu...

Journal: :Haematologica 2008
Anu Usvasalo Riikka Räty Sakari Knuutila Kim Vettenranta Arja Harila-Saari Esa Jantunen Marjut Kauppila Pirjo Koistinen Katriina Parto Pekka Riikonen Toivo T Salmi Raija Silvennoinen Erkki Elonen Ulla M Saarinen-Pihkala

BACKGROUND Interest has recently been paid to adolescents and young adults with acute lymphoblastic leukemia, particularly because all reports so far published indicate that these patients have a better outcome when treated with pediatric rather than adult therapeutic protocols. There are different biological subtypes of acute lymphoblastic leukemia with distinct features and prognoses; the dis...

2017
Blanca Scheijen Judith M. Boer René Marke Esther Tijchon Dorette van Ingen Schenau Esmé Waanders Liesbeth van Emst Laurens T. van der Meer Rob Pieters Gabriele Escherich Martin A. Horstmann Edwin Sonneveld Nicola Venn Rosemary Sutton Luciano Dalla-Pozza Roland P. Kuiper Peter M. Hoogerbrugge Monique L. den Boer Frank N. van Leeuwen

Deletions and mutations affecting lymphoid transcription factor IKZF1 (IKAROS) are associated with an increased relapse risk and poor outcome in B-cell precursor acute lymphoblastic leukemia. However, additional genetic events may either enhance or negate the effects of IKZF1 deletions on prognosis. In a large discovery cohort of 533 childhood B-cell precursor acute lymphoblastic leukemia patie...

Journal: :middle east journal of cancer 0
mahdi shahriari department of pediatrics, hematology oncology branch, shiraz university of medical sciences, shiraz, iran gholamreza fathpour department of pediatrics, hematology oncology branch, shiraz university of medical sciences, shiraz, iran fazl saleh department of pediatrics, hematology oncology branch, shiraz university of medical sciences, shiraz, iran

acute leukemias represent approximately 30% of malignant diseases in patients under the age of 15 years. leukemic infiltration of the central nervous system and testis are common events, particularly as sites of relapse in the third year after diagnosis. management of acute lymphoblastic leukemia is based on long-term chemotherapy, leading to a cure rate of approximately 80% of children and ado...

2018
René Marke Frank N. van Leeuwen Blanca Scheijen

Transcription factor IKZF1 (IKAROS) acts as a critical regulator of lymphoid differentiation and is frequently deleted or mutated in B-cell precursor acute lymphoblastic leukemia. IKZF1 gene defects are associated with inferior treatment outcome in both childhood and adult B-cell precursor acute lymphoblastic leukemia and occur in more than 70% of BCR-ABL1-positive and BCR-ABL1-like cases of ac...

2015
Surya N. Gupta Vikash S. Gupta

Acute polyneuropathy in children with acute lymphoblastic leukemia is extremely rare, but its onset and association with Guillain-Barré syndrome presents a diagnostic challenge. We report a 5-year-old boy who presented with inability to walk during induction chemotherapy for acute lymphoblastic leukemia. Subsequently he developed painful penile erections, difficulty urinating and swallowing. Be...

Journal: :Haematologica 2009
Sara Raponi Maria Stefania De Propris Hobert Wai Stefania Intoppa Loredana Elia Daniela Diverio Antonella Vitale Robin Foà Anna Guarini

Tyrosine kinase inhibitors have profoundly modified the treatment and prognosis of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia. A rapid and accurate detection of the BCR-ABL fusion protein is paramount today for an optimal management of Ph(+) acute lymphoblastic leukemia. We have utilized a recently described and commercialized immunoassay that identifies qualitatively the p...

Journal: :Cancer research 1980
K H Shumak M A Baker R N Taub M S Coleman

Blast cells were obtained from 17 patients with acute undifferentiated leukemia and 13 patients with chronic myelogenous leukemia in blast crisis. The blasts were tested with anti-i serum in cytotoxicity tests and with antisera to myeloblastic leukemia-associated antigens in immunofluorescence tests. The terminal deoxynucleotidyl transferase (TDT) content of the blasts was also measured. Lympho...

Introduction: The objective of this study is to determine the major causes of early death in acute lymphoblastic leukemia (ALL).  Methods: The following databases including PubMed, EMBASE, Science Direct and Google Scholar were searched for following terms: “acute lymphoblastic leukemia”, “early mortality”, “early death “ and “death in induction phase “. Inclusion criteria were all studies abo...

2012
Songul SEREFHANOGLU Hakan GOKER Dilek E. BAYDAR Aysegul UNER Mustafa ARICI Ibrahim C. HAZNEDAROGLU Yahya BUYUKASIK Nilgun SAYINALP Salih AKSU Osman I. OZCEBE

Extramedullary recurrences with or without bone marrow involvement are reported in up to a half of leukemic relapses after bone marrow transplantation. Extramedullary relapse of acute lymphoblastic leukemia (ALL) in the kidney after allogeneic stem cell transplantation (allo-SCT) is rare. We herein, report an additional case with extramedullary recurrences and renal relapse after first-allograf...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید